During the past decade, Toronto Sleep Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Toronto Sleep Institute" are "Narcolepsy" (2 trials), "Obstructive Sleep Apnea" (2 trials), "Insomnia" (1 trials), "Narcolepsy Type 1 (NT 1)" (1 trials) and "Narcolepsy Type 1 (NT1)" (1 trials). Many other conditions were trialed in "Toronto Sleep Institute" in a lesser frequency.

Most popular intervention types in "Toronto Sleep Institute" are "Drug" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "JZP-110" (3 trials), "Placebo" (2 trials), "Placebo oral tablet" (2 trials), "TAK-994" (2 trials) and "Lemborexant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Toronto Sleep Institute" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Toronto Sleep Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Toronto Sleep Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Toronto Sleep Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Toronto Sleep Institute has several departments that took part in Clinical trials: "Mood Disorders Psychopharmacology Unit" - 2 trials